Pratia Hematologia Sp. z o.o. — Clinical Trial Site

91 Registered trials

47 Currently recruiting

Organisation

Pratia Hematologia Sp. z o.o.

Location

Katowice, Poland

Identifier

ORG-100040044

Address

Ul. Tadeusza Kosciuszki 92, 40-519, Poland

Departments

-
#5704 Pratia Onkologia Katowice
#9008: oncology
2141: PRATIA Onkologia Katowice
2806 : Pratia Onkologia Katowice
5702: Hematologia
Hematologia
Hematology
n/a
NA
PL30001:Oncology
Poradnia Onkologiczna
Pratia Onkologia Katowice
Pratia Hematologia Sp. z o.o.
Pratia Onkologia
Pratia Onkologia Katowice
Site name:Pratia Onkologia Katowice, ul. Kosciuszki 92, 40-519 Katowice

Clinical trials at this site (91)

Search interface

Phase Ia/Ib Study of UBX-303061 in Subjects with Relapsed/Refractory B-Cell Malignancies Pending

2023-510484-35-00 B-cell malignancies 1
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Relapsed Refractory Multiple Myeloma 5
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L… Pending

2025-522818-23-00 Small Cell Lung Cancer (SCLC) 5
A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t… Pending

2025-523555-66-00 Myelofibrosis 5
A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma Pending

2025-523815-12-00 Relapsed or Refractory Multiple Myeloma 5
A study of cemsidomide and dexamethasone in subjects with relapsed or refractory multiple myeloma (r/r MM) Pending

2025-524181-26-00 relapsed/refractory multiple myeloma 4
A phase 3 study of orelabrutinib in combination with rituximab plus bendamustine (BR) compared with BR in subjects with treatment-naїve mant… Pending

2025-524241-27-00 Treatment-naїve mantle cell lymphoma (MCL) 5
A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Recruiting

2025-523005-15-00 Non-Hodgkin Lymphoma 9 2026-06-15
A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Recruiting

2025-523586-18-00 Non-Small Cell Lung Cancer 5 2026-06-11
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect… Recruiting

2025-523521-18-00 Metastatic Colorectal Cancer 5 2026-06-09
A Phase 3 Study of DZD8586 versus Investigator’s Choice in r/r CLL/SLL Recruiting

2025-522669-32-00 Relapsed/Refractory Chronic Lymphocytic Leukemia/Small 5 2025-12-18
RVU120 Rollover Study Recruiting

2025-521673-14-00 Relapsed / Refractory Metastatic or Advanced Solid Tumo 4 2025-12-03
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibit… Recruiting

2025-521088-10-00 Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia 4 2025-10-23
A study to compare pharmacokinetics, efficacy, safety, and immunogenicity of MB12 (proposed pembrolizumab biosimilar) to Keytruda® in non-sm… Recruiting

2024-515853-48-00 advanced/metastatic non-squamous non-small cell lung ca 5 2025-09-05
A Study to Investigate the Safety and Efficacy of Pirtobrutinib in Adults with Immune Thrombocytopenia Recruiting

2024-518502-40-00 Immune Thrombocytopenia 9 2025-07-28
A phase 2/3, multi-center, study of L-Annamycin in combination with cytarabine vs. placebo in combination with cytarabine as second line the… Recruiting

2024-518359-47-00 Acute Myeloid Leukemia 10 2025-06-17
A study to assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia Recruiting

2024-515451-38-00 Primary Immune thrombocytopenia (ITP) 5 2025-02-27
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Hematologic Maligna… Recruiting

2024-511457-22-00 Advanced Hematologic Malignancies 3 2025-01-30
A study to compare effects and safety of CT-P51 and Keytruda in patients with previously untreated metastatic lung cancer Recruiting

2024-514048-98-00 Previously Untreated Metastatic Non-Squamous Non-Small 5 2025-01-30
A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting

2022-502660-20-00 Follicular lymphoma 5 2024-01-23
A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY) Recruiting

2022-502548-12-00 marginal zone lymphoma 5 2023-09-28
A Study of AG-946 in Participants With Anaemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS). Recruiting

2022-500609-42-00 Anemia Due to Lower-Risk Myelodysplastic Syndromes 4 2023-02-24
A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Recruiting

2025-523544-12-00 Myelodysplastic neoplasms/syndromes (MDS) 5 2026-06-02
A Phase 3 study of Hetrombopag in patients with low blood platelet count (thrombocytopenia) caused by chemotherapy Recruiting

2025-524209-34-00 Chemotherapy induced thrombocytopenia 5 2026-05-20